Hence, NF-κB is thought to be a target for drugs that fight breast cancer, and the molecular docking study with five major alkaloidal phytoconstituents of the extract showed significant binding affinity towards the active site NF-κB and can act as NF-κB inhibitor (Figure 2). This evidence concerns the gene NFKB1 and breast cancer.